FDA approval summary for lonafarnib (Zokinvy) for the treatment of Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathiesGENETICS IN MEDICINEIF6.22023-02-0117OAAI
Withdrawing Approval of Makena - A Proposal from the FDA Center for Drug Evaluation and ResearchNEW ENGLAND JOURNAL OF MEDICINEIF78.52020-12-1028OAAI
2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials临床试验的2017心血管和卒中终点定义CIRCULATIONIF38.62018-02-27124OAAI
Few predictors of massive deep vein thrombosis大量深静脉血栓形成的几个预测因素THROMBOSIS AND HAEMOSTASISIF4.32017-12-142PREAI
FDA Approval of Flibanserin - Treating Hypoactive Sexual Desire DisorderNEW ENGLAND JOURNAL OF MEDICINEIF78.52016-01-1475OA
Testosterone and Age-Related Hypogonadism - FDA ConcernsNEW ENGLAND JOURNAL OF MEDICINEIF78.52015-08-20147OAAI
FDA Approval of Paroxetine for Menopausal Hot Flushes EDITORIAL COMMENTOBSTETRICAL & GYNECOLOGICAL SURVEYIF3.62014-10-010PREAI
FDA Approval of Paroxetine for Menopausal Hot FlushesNEW ENGLAND JOURNAL OF MEDICINEIF78.52014-05-0852OAAI
Beneficial effects of eplerenone versus hydrochlorothiazide on coronary circulatory function in patients with diabetes mellitusJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISMIF5.12007-07-0172PREAI
Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular diseaseANNALS OF EPIDEMIOLOGYIF32006-02-0156PRE
Upper-extremity deep vein thrombosis - A prospective registry of 592 patientsCIRCULATIONIF38.62004-09-21285OAAI